Tiemann Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $282K | Sell |
563
-40
| -7% | -$19.2K | 0.1% | 149 |
|
|
2026
Q1 | $296K | Buy |
603
+125
| +26% | +$67.8K | 0.12% | 142 |
|
|
2025
Q4 | $277K | Sell |
478
-85
| -15% | -$48.1K | 0.11% | 145 |
|
|
2025
Q3 | $273K | Buy |
563
+44
| +8% | +$20.5K | 0.1% | 154 |
|
|
2025
Q2 | $210K | Sell |
519
-33
| -6% | -$13.8K | 0.09% | 188 |
|
|
2025
Q1 | $275K | Sell |
552
-35
| -6% | -$19K | 0.12% | 144 |
|
|
2024
Q4 | $305K | Hold |
587
| – | – | 0.14% | 131 |
|
|
2024
Q3 | $363K | Sell |
587
-10
| -2% | -$5.92K | 0.16% | 122 |
|
|
2024
Q2 | $330K | Hold |
597
| – | – | 0.15% | 127 |
|
|
2024
Q1 | $347K | Hold |
597
| – | – | 0.16% | 130 |
|
|
2023
Q4 | $317K | Sell |
597
-22
| -4% | -$10.6K | 0.15% | 135 |
|
|
2023
Q3 | $313K | Sell |
619
-25
| -4% | -$13.3K | 0.17% | 123 |
|
|
2023
Q2 | $336K | Sell |
644
-15
| -2% | -$8.09K | 0.17% | 126 |
|
|
2023
Q1 | $380K | Hold |
659
| – | – | 0.21% | 115 |
|
|
2022
Q4 | $363K | Sell |
659
-135
| -17% | -$71.5K | 0.21% | 112 |
|
|
2022
Q3 | $403K | Hold |
794
| – | – | 0.26% | 86 |
|
|
2022
Q2 | $431K | Sell |
794
-2
| -0.3% | -$1.1K | 0.23% | 95 |
|
|
2022
Q1 | $470K | Sell |
796
-24
| -3% | -$13.8K | 0.22% | 101 |
|
|
2021
Q4 | $547K | Buy |
820
+20
| +3% | +$12.5K | 0.23% | 96 |
|
|
2021
Q3 | $457K | Sell |
800
-50
| -6% | -$27.4K | 0.22% | 108 |
|
|
2021
Q2 | $429K | Buy |
850
+10
| +1% | +$4.72K | 0.2% | 121 |
|
|
2021
Q1 | $383K | Sell |
840
-15
| -2% | -$7.16K | 0.19% | 128 |
|
|
2020
Q4 | $398K | Sell |
855
-135
| -14% | -$63.3K | 0.21% | 117 |
|
|
2020
Q3 | $437K | Buy |
990
+15
| +2% | +$6.2K | 0.27% | 92 |
|
|
2020
Q2 | $353K | Buy |
975
+190
| +24% | +$63.7K | 0.24% | 102 |
|
|
2020
Q1 | $223K | Sell |
785
-50
| -6% | -$15.8K | 0.19% | 135 |
|
|
2019
Q4 | $271K | Sell |
835
-50
| -6% | -$15.2K | 0.19% | 141 |
|
|
2019
Q3 | $258K | Sell |
885
-250
| -22% | -$71.6K | 0.19% | 142 |
|
|
2019
Q2 | $333K | Sell |
1,135
-100
| -8% | -$27.5K | 0.24% | 121 |
|
|
2019
Q1 | $338K | Sell |
1,235
-200
| -14% | -$49.8K | 0.26% | 114 |
|
|
2018
Q4 | $321K | Hold |
1,435
| – | – | 0.29% | 105 |
|
|
2018
Q3 | $350K | Hold |
1,435
| – | – | 0.27% | 107 |
|
|
2018
Q2 | $297K | Buy |
1,435
+50
| +4% | +$10.6K | 0.24% | 120 |
|
|
2018
Q1 | $286K | Hold |
1,385
| – | – | 0.23% | 123 |
|
|
2017
Q4 | $263K | Hold |
1,385
| – | – | 0.21% | 137 |
|
|
2017
Q3 | $262K | Hold |
1,385
| – | – | 0.22% | 132 |
|
|
2017
Q2 | $242K | Hold |
1,385
| – | – | 0.22% | 137 |
|
|
2017
Q1 | $213K | Hold |
1,385
| – | – | 0.2% | 155 |
|
|
2016
Q4 | $195K | Hold |
1,385
| – | – | 0.19% | 152 |
|
|
2016
Q3 | $220K | Sell |
1,385
-40
| -3% | -$6.16K | 0.2% | 153 |
|
|
2016
Q2 | $211K | Sell |
1,425
-200
| -12% | -$29.5K | 0.2% | 151 |
|
|
2016
Q1 | $230K | Buy |
1,625
+150
| +10% | +$20.1K | 0.23% | 137 |
|
|
2015
Q4 | $209K | Buy |
+1,475
| New | +$197K | 0.21% | 150 |
|
|
2014
Q4 | – | Sell |
-1,700
| Closed | -$207K | – | 148 |
|
|
2014
Q3 | $207K | Hold |
1,700
| – | – | 0.23% | 137 |
|
|
2014
Q2 | $201K | Sell |
1,700
-200
| -11% | -$23.5K | 0.22% | 139 |
|
|
2014
Q1 | $228K | Sell |
1,900
-25
| -1% | -$2.97K | 0.26% | 126 |
|
|
2013
Q4 | $214K | Buy |
+1,925
| New | +$191K | 0.25% | 130 |
|
Other funds holding TMO
Tiemann Investment Advisors's TMO Position: Q2 2026 in Review
Tiemann Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.6% in Q2 2026, selling an estimated $19.2K and leaving 563 shares worth $282K. The position accounts for 0.1% of the portfolio, ranked #149.
Tiemann Investment Advisors first reported a position in TMO in Q4 2013 and has held it in 47 quarters since. The position peaked at $547K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Tiemann Investment Advisors held 563 shares of Thermo Fisher Scientific worth $282K as of Q2 2026.
- Tiemann Investment Advisors sold 40 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.2K.
- Thermo Fisher Scientific made up 0.1% of Tiemann Investment Advisors's portfolio in Q2 2026, its #149 holding.
- Tiemann Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 47 quarters since.
- Tiemann Investment Advisors's Thermo Fisher Scientific position peaked at $547K in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Tiemann Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.